Patierno, CA 126: 128993, 1996.* |
Berthois, CA 106: 79004, 1986.* |
Inoue, CA 111: 115707, 1988.* |
Rose, CA 121:292186, 1994.* |
Hatala, CA 119:267816, 1993.* |
Manyak et al., J. Urology 140:176-182 (1988). |
Broers et al., Laboratory Investigation 66(3) : 337-346 (1992). |
Miyamoto et al., J. Urology 149: 1015-1019 (May 1993). |
Jensen et al., Int. J. Cancer 58: 629-637 (1994). |
Linnoila et al., A.J.C.P. 97(2) : 223-243 (Feb. 1992). |
Peri et al., J. Clinical Inv. 92: 2099-2109 (Nov. 1993). |
Morgan et al., Annu. Rev. Biochem. 62: 191-217 (1993). |
Tolstoshev, Annu. Rev. Pharmocol. Toxicol. 32: 573-96 (1993). |
Hill, R.R., Chapter 11, Metastasis, pp. 178-95 in The Basic Science of Onocology, Tannock et al., Eds., McGraw-Hill, N.Y. (1992). |
Aznavoorian et al., Cancer, 71: 1368-83 (1993). |
Singh et al., BBA, 950: 329-337 (1988). |
Miele et al., Endocrine Reviews, 8: 474-90 (1987). |
Nieto et al., Arch. Biochem. Biophys., 180: 82-92 (1977). |
Mantile et al., J. Biol. Chem., 268: 20343-20351 (1993). |
Miele et al, J. Biol. Chem., 265: 6427-35 (1990). |
Sambrook et al., Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (1989). |
Arcone et al., Eur. J. Biochem., 211: 347-55 (1993). |
Cirino et al., British J. Pharmacol., 108:573-4 (1993). |
Bastian et al., J. Invest. Dermatol.101:359-63 (1993). |
Monoclonal Antibodies—Production, Engineering and Clinical Applications, Ritter et al., Eds., Cambridge University Press, Cambridge, UK (1995). |
Merk Index, 11th Ed., Budavari et al, Eds., Merk & Co., Inc. Rahway, N.J. (1989). |
Goodman and Gilman's: The Pharmacological Bases of Therapeutics, 8th Ed., Gilman et al., Eds., Pergamon Press (1990). |
Remington's Pharmaceutical Sciences, 17th Ed., Mack Publishing Co., Easton, PA (1990). |
Cancer Therapy With Radiolabeled Antibodies, D.M. Goldenberg, Ed., CRC Press, Boca Raton, FL (1995). |
Stone et al., Int. J. Cancer, 21: 274-281 (1978). |
Horoszewicz et al., Cancer Res., 43: 1809-18 (1983). |
Kaighn et al., Invent Urol., 17: 16-23 (1979). |
Hzumi et al., J. Urology, 137: 1304-1306 (1987). |
Albini et al., Cancer Research, 47: 3239-3245 (1987). |
Leyton et al., Cancer Research, 54: 3696-3699 (1994). |
Frandson et al., Fibrinolysis, 6 (Supp. 4): 71-76 (1992). |
Manyak et al., J. Urology, 151: 368A (1994). |
Cerbón et al., J. steroid Biochem., 36: 1-6 (1990). |
López de Haro et al., FEBS LETTERS, 232: 351-353 (1988). |
Aumuller et al., Histochemistry, 83: 413-417 (1985). |
Tibes et al., Expert Opin. Invest. Drugs, 6: 279-298 (1997). |
Dannhorn et al., J. Immunol. Meth., 119: 223-230 (1989). |
Osband et al., Immunology Today, 11: 193-195 (1990). |
Mayer et al., Expert Opin. Invest. Drugs, 5: 535-554 (1996). |
Leyton et al., Proc. Amer. Assoc. Canc. Res. 35: 280 (1994). |